Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 2

Interventions

Adalimumab 10Etanercept 9Methotrexate 4Infliximab 3tofacitinib 2Rituximab 2Leflunomide 2Abatacept 2tocilizumab 1sarilumab 1golimumab 1entecavir 1Tumor Necrosis Factor Inhibitors 1Sulfasalazine 1Prednisone 1Licensure 1Hydroxychloroquine 1Glucocorticoids 1Folic Acid 1Chloroquine 1Certolizumab Pegol 1Azathioprine 1Antirheumatic Agents 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Arthritis, Rheumatoid × Leflunomide × Clear all
NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed
84 enrolled 36 charts

Arthritis, Rheumatoid

NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Central South University

Phase 4 Unknown
240 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡